JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Peter Pastuszko
J. William Gaynor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pastuszko, P.
Right arrow Articles by Gaynor, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pastuszko, P.
Right arrow Articles by Gaynor, J. W.
Related Collections
Right arrow Cardiac - other
Right arrow Congenital - acyanotic
Right arrow Congenital - cyanotic
Right arrow Molecular biology

J Thorac Cardiovasc Surg 2005;129:1447-1448
© 2005 The American Association for Thoracic Surgery


Brief Communication

Hemoptysis after CardioSEAL device embolization of a venous collateral after the Fontan operation

Peter Pastuszko, MDa, Jonathan J. Rome, MDb, Marie M. Gleason, MDb, Richard D. Bellah, MDc, Lisa M. Montenegro, MDd, J. William Gaynor, MDa,*

a Division of Cardiothoracic Surgery, The Cardiac Center at The Children’s Hospital of Philadelphia, Philadelphia, Pa.
b Division of Cardiology, The Cardiac Center at The Children’s Hospital of Philadelphia, Philadelphia, Pa.
c Division of Radiology, The Cardiac Center at The Children’s Hospital of Philadelphia, Philadelphia, Pa.
d Division of Cardiac Anesthesiology, The Cardiac Center at The Children’s Hospital of Philadelphia, Philadelphia, Pa.

Received for publication October 15, 2004; accepted for publication October 28, 2004.

* Address for reprints: J. William Gaynor, MD, Division of Cardiothoracic Surgery, Suite 8527, The Children’s Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104 (Email: gaynor{at}email.chop.edu).

Transcatheter closure of septal defects and other vascular structures in children is a rapidly evolving field with a growing number of applications for the currently available devices. Despite the widely accepted use of these closure devices for lesions such as atrial septal defects and patent ductus arteriosus, their use in the treatment of other defects is limited. Consequently, little is known about the associated risks and complications. We present here a case of a delayed complication of airway erosion from a CardioSEAL device (NMT Medical, Boston, Mass) used to close a large anomalous systemic to pulmonary venous channel after the Fontan operation.

Clinical Summary

An 18-year-old man with a functional single ventricle presented with recurrent hemoptysis. He had undergone staged reconstructive surgery with Fontan completion at 18 months of age. At the age of 13 years, he was noted to have decreased arterial oxygen saturations. Cardiac catheterization revealed a large decompressing vein from the superior vena cava to the right pulmonary vein. Criteria were met for entry into the CardioSEAL High Risk Device Trial (sponsor: Children’s Hospital, Boston, Mass), and informed consent was obtained. The vascular channel was closed with a CardioSEAL device. Five years later, he presented initially with a cough and subsequently with hemoptysis and recurrent desaturation. Catheterization revealed a left pulmonary artery stenosis, but no cause for the hemoptysis. Several weeks later he presented with recurrent hemoptysis. The chest x-ray film was essentially unremarkable, but a computed tomographic scan revealed erosion of the CardioSEAL device into the right main-stem bronchus (Figure 1). Bronchoscopy confirmed the erosion of the device through the lumen of the right upper lobe bronchus, nearly obstructing the right main-stem bronchus. The device was removed through a right thoracotomy. There was extensive inflammation and scarring, and the device was adherent to the right pulmonary artery. Because of the dense adhesions, it was not possible to obtain proximal control of the pulmonary artery. Cardiopulmonary bypass support was used, and a right upper lobectomy with repair of the pulmonary artery was performed. On follow-up, there has been no hemoptysis 7 months after surgery.


Figure 1
View larger version (110K):
[in this window]
[in a new window]
 
Figure 1. A, Chest x-ray film shows vascular occlusive device in right paratracheal area. B, Contrast computed tomography scan (magnified view) shows vascular occlusive device (short arrow) with posterior limb (long arrow) eroding into the right main bronchus.

 
Discussion

There is extensive experience with the use of endovascular devices for closure of intracardiac defects and patent ductus arteriosus. However, there is little information on the use of these devices for intrapulmonary occlusions. The CardioSEAL double umbrella device (NMT Medical) was approved in the United States for closure of muscular ventricular septal defects in December 2001. Successful use of this device has been reported in occlusion of a large pulmonary arteriovenous malformation in an adult patient with hereditary hemorrhagic telangiectasia.1 In our patient this type of device was used to close an intrapulmonary vein. The procedure was successful; however, the patient returned 5 years later with hemoptysis secondary to erosion of the device into the right upper lobe bronchus. To our knowledge, this is the first reported case of such a complication. In a recent review of a group of 417 patients who underwent a device closure of secundum atrial septal defect, Chessa and associates2 reported an 8.6% incidence of complications. The most common complication was a device malposition or embolization (3.5%). Seven patients required surgical intervention after device embolization. No erosions were reported in this series; however, hemopericardium and fistula formation have been described after atrial septal defect closure.3,4 The mechanism of erosion is unknown, but it is likely that it is due at least in part to persistent pressure to the endovascular surface from a constrained device. In our case the arms of the CardioSEAL were partially collapsed in the vascular structure.

The use of stents, coils, and other intravascular devices has grown dramatically in the last several years. As their use increases, so does recognition of their limitations and the potential complications of migration and embolization. Intravascular foreign body migration is a well-documented phenomenon, particularly for intracardiac missiles and missile emboli. Previously, foreign body removal was advocated for most cases; however, a more selective approach has recently been advocated.5 The unstable nature of intravascular foreign bodies continues to be stressed.

The use of percutaneous interventional techniques for the treatment of congenital cardiac disease will continue to increase. However, the natural history of intravascular devices is not well known. Intravascular foreign objects have a tendency to erode into the surrounding structures and to migrate. As use of intravascular devices continues to expand, close follow-up of these patients is necessary.

References

  1. Apostolopoulou SC, Kelekis NL, Papagiannis J, Hausdorf G, Rammos S. Transcatheter occlusion of a large pulmonary arteriovenous malformation with use of a Cardioseal device. J Vasc Interv Radiol 2001;12:767-769.[Medline]
  2. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.[Abstract/Free Full Text]
  3. Ewert P, Kretschmar O, Peters B, et al. Preliminary experience with a new 18 mm Amplatzer PFO occluder for small persistent foramen ovale. Catheter Cardiovasc Interv 2003;59:518-521Aug.[Medline]
  4. Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2003;58:246-251.[Medline]
  5. Symbas PN, Picone AL, Hatcher CR, Vlasis-Hale SE. Cardiac missiles. A review of the literature and personal experience. Ann Surg 1990;211:639-648.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Peter Pastuszko
J. William Gaynor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pastuszko, P.
Right arrow Articles by Gaynor, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pastuszko, P.
Right arrow Articles by Gaynor, J. W.
Related Collections
Right arrow Cardiac - other
Right arrow Congenital - acyanotic
Right arrow Congenital - cyanotic
Right arrow Molecular biology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS